Footprints of antigen processing boost MHC class II natural ligand predictions

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Footprints of antigen processing boost MHC class II natural ligand predictions. / Barra, Carolina; Alvarez, Bruno; Paul, Sinu; Sette, Alessandro; Peters, Bjoern; Andreatta, Massimo; Buus, Søren; Nielsen, Morten.

I: Genome Medicine, Bind 10, 84, 2018.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Barra, C, Alvarez, B, Paul, S, Sette, A, Peters, B, Andreatta, M, Buus, S & Nielsen, M 2018, 'Footprints of antigen processing boost MHC class II natural ligand predictions', Genome Medicine, bind 10, 84. https://doi.org/10.1186/s13073-018-0594-6

APA

Barra, C., Alvarez, B., Paul, S., Sette, A., Peters, B., Andreatta, M., Buus, S., & Nielsen, M. (2018). Footprints of antigen processing boost MHC class II natural ligand predictions. Genome Medicine, 10, [84]. https://doi.org/10.1186/s13073-018-0594-6

Vancouver

Barra C, Alvarez B, Paul S, Sette A, Peters B, Andreatta M o.a. Footprints of antigen processing boost MHC class II natural ligand predictions. Genome Medicine. 2018;10. 84. https://doi.org/10.1186/s13073-018-0594-6

Author

Barra, Carolina ; Alvarez, Bruno ; Paul, Sinu ; Sette, Alessandro ; Peters, Bjoern ; Andreatta, Massimo ; Buus, Søren ; Nielsen, Morten. / Footprints of antigen processing boost MHC class II natural ligand predictions. I: Genome Medicine. 2018 ; Bind 10.

Bibtex

@article{d2ef3e9c8b8e4e038e9aa1c3be9d7c57,
title = "Footprints of antigen processing boost MHC class II natural ligand predictions",
abstract = "BACKGROUND: Major histocompatibility complex class II (MHC-II) molecules present peptide fragments to T cells for immune recognition. Current predictors for peptide to MHC-II binding are trained on binding affinity data, generated in vitro and therefore lacking information about antigen processing. METHODS: We generate prediction models of peptide to MHC-II binding trained with naturally eluted ligands derived from mass spectrometry in addition to peptide binding affinity data sets. RESULTS: We show that integrated prediction models incorporate identifiable rules of antigen processing. In fact, we observed detectable signals of protease cleavage at defined positions of the ligands. We also hypothesize a role of the length of the terminal ligand protrusions for trimming the peptide to the MHC presented ligand. CONCLUSIONS: The results of integrating binding affinity and eluted ligand data in a combined model demonstrate improved performance for the prediction of MHC-II ligands and T cell epitopes and foreshadow a new generation of improved peptide to MHC-II prediction tools accounting for the plurality of factors that determine natural presentation of antigens.",
keywords = "Antigen processing, Binding predictions, Eluted ligands, Machine learning, Mass spectrometry, MHC-II, Neural networks, T cell epitope",
author = "Carolina Barra and Bruno Alvarez and Sinu Paul and Alessandro Sette and Bjoern Peters and Massimo Andreatta and S{\o}ren Buus and Morten Nielsen",
year = "2018",
doi = "10.1186/s13073-018-0594-6",
language = "English",
volume = "10",
journal = "Genome Medicine",
issn = "1756-994X",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - Footprints of antigen processing boost MHC class II natural ligand predictions

AU - Barra, Carolina

AU - Alvarez, Bruno

AU - Paul, Sinu

AU - Sette, Alessandro

AU - Peters, Bjoern

AU - Andreatta, Massimo

AU - Buus, Søren

AU - Nielsen, Morten

PY - 2018

Y1 - 2018

N2 - BACKGROUND: Major histocompatibility complex class II (MHC-II) molecules present peptide fragments to T cells for immune recognition. Current predictors for peptide to MHC-II binding are trained on binding affinity data, generated in vitro and therefore lacking information about antigen processing. METHODS: We generate prediction models of peptide to MHC-II binding trained with naturally eluted ligands derived from mass spectrometry in addition to peptide binding affinity data sets. RESULTS: We show that integrated prediction models incorporate identifiable rules of antigen processing. In fact, we observed detectable signals of protease cleavage at defined positions of the ligands. We also hypothesize a role of the length of the terminal ligand protrusions for trimming the peptide to the MHC presented ligand. CONCLUSIONS: The results of integrating binding affinity and eluted ligand data in a combined model demonstrate improved performance for the prediction of MHC-II ligands and T cell epitopes and foreshadow a new generation of improved peptide to MHC-II prediction tools accounting for the plurality of factors that determine natural presentation of antigens.

AB - BACKGROUND: Major histocompatibility complex class II (MHC-II) molecules present peptide fragments to T cells for immune recognition. Current predictors for peptide to MHC-II binding are trained on binding affinity data, generated in vitro and therefore lacking information about antigen processing. METHODS: We generate prediction models of peptide to MHC-II binding trained with naturally eluted ligands derived from mass spectrometry in addition to peptide binding affinity data sets. RESULTS: We show that integrated prediction models incorporate identifiable rules of antigen processing. In fact, we observed detectable signals of protease cleavage at defined positions of the ligands. We also hypothesize a role of the length of the terminal ligand protrusions for trimming the peptide to the MHC presented ligand. CONCLUSIONS: The results of integrating binding affinity and eluted ligand data in a combined model demonstrate improved performance for the prediction of MHC-II ligands and T cell epitopes and foreshadow a new generation of improved peptide to MHC-II prediction tools accounting for the plurality of factors that determine natural presentation of antigens.

KW - Antigen processing

KW - Binding predictions

KW - Eluted ligands

KW - Machine learning

KW - Mass spectrometry

KW - MHC-II

KW - Neural networks

KW - T cell epitope

U2 - 10.1186/s13073-018-0594-6

DO - 10.1186/s13073-018-0594-6

M3 - Journal article

C2 - 30446001

AN - SCOPUS:85056738224

VL - 10

JO - Genome Medicine

JF - Genome Medicine

SN - 1756-994X

M1 - 84

ER -

ID: 210064011